Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Contineum Therapeutics (CTNM) Return on Sales (2023 - 2024)

Historic Return on Sales for Contineum Therapeutics (CTNM) over the last 2 years, with Q1 2024 value amounting to 0.38%.

  • Contineum Therapeutics' Return on Sales fell 520500.0% to 0.38% in Q1 2024 from the same period last year, while for Mar 2024 it was 0.38%, marking a year-over-year change of. This contributed to the annual value of 0.45% for FY2023, which is N/A changed from last year.
  • Per Contineum Therapeutics' latest filing, its Return on Sales stood at 0.38% for Q1 2024, which was down 520500.0% from 0.46% recorded in Q4 2023.
  • Over the past 5 years, Contineum Therapeutics' Return on Sales peaked at 52.43% during Q1 2023, and registered a low of 0.38% during Q1 2024.